Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02864355 · ClinicalTrials.gov registry record · NA
Does Perioperative Goal Directed Therapy Using Flotrac Improve Outcomes in Esophagectomy Patients
A NA study, sponsored by Medical University of South Carolina.
- Terminated
- Registry status
- NA
- Development phase
- 53
- Enrollment target
NCT02864355 is a NA study that was terminated before completion, run by Medical University of South Carolina. The registered enrollment target is 53 participants.
The verdict
NCT02864355, a NA study, was terminated before completion, sponsored by Medical University of South Carolina.
- TERMINATED
- Registry status
- NA
- Development phase
- 53 participants
- Enrollment target
Study Summary
The objective of this prospective, randomized controlled study is to ascertain whether the perioperative use of the FloTrac device to guide fluid and vasopressor management during esophagectomy improves patient outcomes. The primary outcome is cardiopulmonary complications; however, the secondary outcome of decreasing patient morbidity (acute renal injury, anastomotic leak, and overall length of both ICU (intensive care unit) and hospital stay.
Interventions
- DEVICE Goal Directed Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2016-06 |
| Est. Completion | 2020-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02864355
The ClinicalTrials.gov registry entry for NCT02864355 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Goal Directed Therapy is the first listed.
NCT02864355 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02864355 about?
NCT02864355 is a clinical study titled "Does Perioperative Goal Directed Therapy Using Flotrac Improve Outcomes in Esophagectomy Patients". The objective of this prospective, randomized controlled study is to ascertain whether the perioperative use of the FloTrac device to guide fluid and vasopressor management during esophagectomy improves patient outcomes. The primary outcome is cardiopulmonary complications; however, the secondary ou...
What is the current status of trial NCT02864355?
This trial is currently terminated. It is a NA study. The enrollment target is 53 participants. The study started on 2016-06. Estimated completion is 2020-03.
What interventions are being tested in trial NCT02864355?
The interventions under investigation include: Goal Directed Therapy (DEVICE).
Who is sponsoring clinical trial NCT02864355?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.